- Home
- FNWB vs ICCM Comparison
FNWB vs ICCM Comparison
Compare FNWB & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- ICCM
- Stock Information
- Founded
- FNWB 1923
- ICCM 2006
- Country
- FNWB United States
- ICCM Israel
- Employees
- FNWB N/A
- ICCM N/A
- Industry
- FNWB Banks
- ICCM
- Sector
- FNWB Finance
- ICCM
- Exchange
- FNWB Nasdaq
- ICCM Nasdaq
- Market Cap
- FNWB 87.2M
- ICCM 70.1M
- IPO Year
- FNWB 2015
- ICCM N/A
- Fundamental
- Price
- FNWB $9.81
- ICCM $1.14
- Analyst Decision
- FNWB Hold
- ICCM Strong Buy
- Analyst Count
- FNWB 1
- ICCM 1
- Target Price
- FNWB $12.00
- ICCM $2.50
- AVG Volume (30 Days)
- FNWB 15.1K
- ICCM 212.7K
- Earning Date
- FNWB 04-28-2025
- ICCM 05-27-2025
- Dividend Yield
- FNWB 2.84%
- ICCM N/A
- EPS Growth
- FNWB N/A
- ICCM N/A
- EPS
- FNWB N/A
- ICCM N/A
- Revenue
- FNWB $50,900,000.00
- ICCM $3,291,000.00
- Revenue This Year
- FNWB $42.48
- ICCM $97.02
- Revenue Next Year
- FNWB $11.60
- ICCM $212.86
- P/E Ratio
- FNWB N/A
- ICCM N/A
- Revenue Growth
- FNWB N/A
- ICCM 1.92
- 52 Week Low
- FNWB $8.91
- ICCM $0.48
- 52 Week High
- FNWB $12.10
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- FNWB 43.79
- ICCM 45.35
- Support Level
- FNWB $9.55
- ICCM $1.09
- Resistance Level
- FNWB $9.94
- ICCM $1.16
- Average True Range (ATR)
- FNWB 0.44
- ICCM 0.08
- MACD
- FNWB -0.03
- ICCM 0.00
- Stochastic Oscillator
- FNWB 21.49
- ICCM 42.57
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.